Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

BACKGROUND: Staphylococcus aureus bacteraemia is a common and serious infection, with an associated mortality of ~25%. Once in the blood, S. aureus can disseminate to infect almost any organ, but bones, joints and heart valves are most frequently affected. Despite the infection's severity, the...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Thwaites, G, Auckland, C, Barlow, G, Cunningham, R, Davies, G, Edgeworth, J, Greig, J, Hopkins, S, Jeyaratnam, D, Jenkins, N, Llewelyn, M, Meisner, S, Nsutebu, E, Planche, T, Read, R, Scarborough, M, Soares, M, Tilley, R, Török, M, Williams, J, Wilson, P, Wyllie, S, Walker, A
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2012

Adjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.

Παρόμοια τεκμήρια